{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:29:07Z","timestamp":1794014947155,"version":"4.8.0"},"reference-count":281,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31970739"],"award-info":[{"award-number":["31970739"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273485"],"award-info":[{"award-number":["82273485"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470591"],"award-info":[{"award-number":["82470591"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515012466"],"award-info":[{"award-number":["2024A1515012466"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515010598"],"award-info":[{"award-number":["2022A1515010598"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017607","name":"Shenzhen Municipal Fundamental Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.neuropharm.2025.110754","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T21:01:05Z","timestamp":1762462865000},"page":"110754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The association of the Wnt\/\u03b2-catenin signaling pathway with Alzheimer's disease"],"prefix":"10.1016","volume":"283","author":[{"given":"JiaYing","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4044-2332","authenticated-orcid":false,"given":"Qi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110754_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neuro.2022.05.002","article-title":"Melatonin and zinc supplements with physical and mental activities subside neurodegeneration and hepatorenal injury induced by aluminum chloride in rats: inclusion of GSK-3\u03b2-Wnt\/\u03b2-catenin signaling pathway","volume":"91","author":"Abu-Elfotuh","year":"2022","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2025.110754_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1208252","article-title":"The protective effects of sesamol and\/or the probiotic, Lactobacillus rhamnosus, against aluminum chloride-induced neurotoxicity and hepatotoxicity in rats: modulation of Wnt\/\u03b2-catenin\/GSK-3\u03b2, JAK-2\/STAT-3, PPAR-\u03b3, inflammatory, and apoptotic pathways","volume":"14","author":"Abu-Elfotuh","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15082063","article-title":"Anti-Alzheimer activity of combinations of cocoa with vinpocetine or other nutraceuticals in rat model: Modulation of Wnt3\/\u03b2-Catenin\/GSK-3\u03b2\/Nrf2\/HO-1 and PERK\/CHOP\/Bcl-2 pathways","volume":"15","author":"Abu-Elfotuh","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neuropharm.2025.110754_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.117731","article-title":"The potential anti-alzheimer's activity of Oxalis corniculata Linn. Methanolic extract in experimental rats: role of APOE4\/LRP1, TLR4\/NF-\u03ba\u03b2\/NLRP3, Wnt 3\/\u03b2-catenin\/GSK-3\u03b2, autophagy and apoptotic cues","volume":"324","author":"Abu-Elfotuh","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib5","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.neuron.2016.07.042","article-title":"How to make an active Zone: unexpected universal functional redundancy between RIMs and RIM-BPs","volume":"91","author":"Acuna","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110754_bib6","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.neuroscience.2010.05.078","article-title":"Curcuminoids enhance memory in an amyloid-infused rat model of Alzheimer's disease","volume":"169","author":"Ahmed","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110754_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810572","article-title":"Glial cell-mediated neuroinflammation in Alzheimer's Disease","volume":"23","author":"Al-Ghraiybah","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib8","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2174\/1874467214666210902115650","article-title":"Impact of sitagliptin on non-diabetic Covid-19 patients","volume":"15","author":"Al-Kuraishy","year":"2022","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib9","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s11064-022-03817-4","article-title":"A potential link between visceral obesity and risk of Alzheimer's Disease","volume":"48","author":"Al-Kuraishy","year":"2023","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2025.110754_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102810","article-title":"The potential role of aryl hydrocarbon receptor in Alzheimer's disease: protective or detrimental","volume":"110","author":"Al-Kuraishy","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuropharm.2025.110754_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/npr2.12525","article-title":"Alterations in the processing of Platelet APP (amyloid beta precursor protein) in alzheimer disease: the possible nexus","volume":"45","author":"Al-Kuraishy","year":"2025","journal-title":"Neuropsychop. Rep"},{"key":"10.1016\/j.neuropharm.2025.110754_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1494101","article-title":"Amyloid-\u03b2 and heart failure in Alzheimer's disease: the new vistas","volume":"12","author":"Al-Kuraishy","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.neuropharm.2025.110754_bib13","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1007\/s10787-025-01796-w","article-title":"Targeting the JAK\/STAT3\/SOCS signaling pathway in Alzheimer's disease","volume":"33","author":"Al-Kuraishy","year":"2025","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110754_bib14","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1007\/s10571-023-01392-y","article-title":"Primary hypothyroidism and Alzheimer's Disease: a tale of two","volume":"43","author":"AlAnazi","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/jpi.12238","article-title":"Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3\/Akt\/GSk3\u03b2 pathway in the mouse hippocampus","volume":"59","author":"Ali","year":"2015","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.neuropharm.2025.110754_bib16","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/alz.13016","article-title":"2023 Alzheimer's disease facts and figures","volume":"19","year":"2023","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuropharm.2025.110754_bib17","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1002\/alz.13809","article-title":"2024 Alzheimer's disease facts and figures","volume":"20","year":"2024","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuropharm.2025.110754_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105198","article-title":"Deficient astrocyte metabolism impairs glutamine synthesis and neurotransmitter homeostasis in a mouse model of Alzheimer's disease","volume":"148","author":"Andersen","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2025.110754_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fphar.2019.00271","article-title":"Icariin and its metabolites as potential protective phytochemicals against Alzheimer's Disease","volume":"10","author":"Angeloni","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41419-017-0215-0","article-title":"A key role for MAM in mediating mitochondrial dysfunction in Alzheimer disease","volume":"9","author":"Area-Gomez","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2025.110754_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109793","article-title":"Neuroprotective effect of PPAR alpha and gamma agonists in a mouse model of amyloidogenesis through modulation of the Wnt\/beta catenin pathway via targeting alpha- and beta-secretases","volume":"97","author":"Assaf","year":"2020","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110754_bib22","first-page":"263","article-title":"The Alzheimer's Disease clinical spectrum: diagnosis and management","volume":"103","author":"Atri","year":"2019","journal-title":"Med. Clin."},{"key":"10.1016\/j.neuropharm.2025.110754_bib23","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jasms.2007.02.009","article-title":"Stable isotope labeling tandem mass spectrometry (SILT) to quantify protein production and clearance rates","volume":"18","author":"Bateman","year":"2007","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.neuropharm.2025.110754_bib24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00210-022-02325-0","article-title":"Commiphora myrrh: a phytochemical and pharmacological update","volume":"396","author":"Batiha","year":"2023","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.neuropharm.2025.110754_bib25","doi-asserted-by":"crossref","first-page":"9107","DOI":"10.1021\/jm201724m","article-title":"Discovery of novel potent and highly selective glycogen synthase kinase-3\u03b2 (GSK3\u03b2) inhibitors for Alzheimer's disease: design, synthesis, and characterization of pyrazines","volume":"55","author":"Berg","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2025.110754_bib26","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbadis.2004.08.014","article-title":"Tau, tangles, and Alzheimer's disease","volume":"1739","author":"Binder","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2025.110754_bib28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13024-022-00536-w","article-title":"The role of ATP-binding cassette subfamily A in the etiology of Alzheimer's disease","volume":"17","author":"Bossaerts","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2025.110754_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25245789","article-title":"Comprehensive review on Alzheimer's Disease: causes and treatment","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2025.110754_bib30","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/jnc.13216","article-title":"Dickkopf-related protein 3 is a potential A\u03b2-associated protein in Alzheimer's Disease","volume":"134","author":"Bruggink","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110754_bib31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of aducanumab in early Alzheimer's Disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J. Prev. Alzheimers. Dis"},{"key":"10.1016\/j.neuropharm.2025.110754_bib32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fnsyn.2018.00038","article-title":"Deficient wnt signaling and synaptic vulnerability in Alzheimer's Disease: emerging roles for the LRP6 receptor","volume":"10","author":"Buechler","year":"2018","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib33","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib35","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1523\/JNEUROSCI.1381-04.2004","article-title":"Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain","volume":"24","author":"Caricasole","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib36","doi-asserted-by":"crossref","first-page":"9566","DOI":"10.1021\/acsomega.0c00898","article-title":"Computationally designed sesamol derivatives proposed as potent antioxidants","volume":"5","author":"Castro-Gonz\u00e1lez","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.neuropharm.2025.110754_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.emboj.7600460","article-title":"FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development","volume":"24","author":"Chamorro","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2025.110754_bib38","doi-asserted-by":"crossref","first-page":"8744","DOI":"10.1038\/srep08744","article-title":"N-butylidenephthalide attenuates Alzheimer's disease-like cytopathy in Down syndrome induced pluripotent stem cell-derived neurons","volume":"5","author":"Chang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110754_bib39","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2025.110754_bib40","first-page":"313","article-title":"Alteration of the Wnt\/GSK3\u03b2\/\u03b2-catenin signalling pathway by rapamycin ameliorates pathology in an Alzheimer's disease model","volume":"44","author":"Chen","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.neuropharm.2025.110754_bib41","doi-asserted-by":"crossref","first-page":"10490","DOI":"10.1021\/acs.jafc.2c02665","article-title":"Carnosol reduced pathogenic protein aggregation and cognitive impairment in neurodegenerative diseases models via improving proteostasis and ameliorating mitochondrial disorders","volume":"70","author":"Chen","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.neuropharm.2025.110754_bib42","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fncel.2019.00295","article-title":"Presymptomatic treatment with andrographolide improves brain metabolic markers and cognitive behavior in a model of early-onset Alzheimer's Disease","volume":"13","author":"Cisternas","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib43","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","article-title":"Wnt\/beta-catenin signaling in development and disease","volume":"127","author":"Clevers","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2025.110754_bib44","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12515","article-title":"Melatonin induces mechanisms of brain resilience against neurodegeneration","volume":"65","author":"Corpas","year":"2018","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.neuropharm.2025.110754_bib45","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.nbd.2011.09.002","article-title":"Activation of glycogen synthase kinase-3 beta mediates \u03b2-amyloid induced neuritic damage in Alzheimer's disease","volume":"45","author":"DaRocha-Souto","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2025.110754_bib46","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1042\/CBI20110541","article-title":"Inhibition of GSK-3\u03b2 enhances neural differentiation in unrestricted somatic stem cells","volume":"36","author":"Dastjerdi","year":"2012","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.neuropharm.2025.110754_bib47","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/jnnp-2022-329136","article-title":"Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer's disease: systematic review and meta-analysis","volume":"93","author":"David","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110754_bib48","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.mp.4001208","article-title":"Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils","volume":"8","author":"De Ferrari","year":"2003","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110754_bib49","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2174\/1871527312666131223113900","article-title":"Wnt\/\u03b2-catenin signaling in Alzheimer's disease","volume":"13","author":"De Ferrari","year":"2014","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.neuropharm.2025.110754_bib51","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/cns.12269","article-title":"Wnt signaling pathway, a potential target for Alzheimer's disease treatment, is activated by a novel multitarget compound ASS234","volume":"20","author":"del Pino","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2025.110754_bib52","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3233\/JAD-220320","article-title":"Urokinase-Type plasminogen activator triggers Wingless\/Int1-Independent phosphorylation of the low-density lipoprotein receptor-related Protein-6 in cerebral cortical neurons","volume":"89","author":"Diaz","year":"2022","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.neuropharm.2025.110754_bib53","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11427-018-9350-1","article-title":"Anti-diabetic vanadyl complexes reduced Alzheimer's disease pathology independent of amyloid plaque deposition","volume":"62","author":"Dong","year":"2019","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib54","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.7150\/ijbs.65476","article-title":"Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt\/\u03b2-catenin pathway","volume":"18","author":"Dong","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib55","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s40203-024-00226-z","article-title":"Targeting of wnt signalling pathway by small bioactive molecules for the treatment of Alzheimer's disease","volume":"12","author":"Dutta","year":"2024","journal-title":"Silico. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ma14123332","article-title":"Action mechanisms of curcumin in Alzheimer's Disease and its brain targeted delivery","volume":"14","author":"Ege","year":"2021","journal-title":"Materials"},{"key":"10.1016\/j.neuropharm.2025.110754_bib57","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00109-005-0025-1","article-title":"The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt\/beta-catenin pathway rescue in PC12 cells","volume":"84","author":"Esposito","year":"2006","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.neuropharm.2025.110754_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.635880","article-title":"(Dys)regulation of synaptic activity and neurotransmitter release by \u03b2-Amyloid: a look beyond Alzheimer's Disease pathogenesis","volume":"14","author":"Fagiani","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.893118","article-title":"Mechanisms underlying curcumin-induced neuroprotection in cerebral ischemia","volume":"13","author":"Fan","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib60","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1007\/s12035-024-04462-4","article-title":"Unlocking hope: therapeutic advances and approaches in modulating the wnt pathway for neurodegenerative diseases","volume":"62","author":"Faraji","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib61","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.nbd.2004.09.012","article-title":"The anti-inflammatory and cholinesterase inhibitor bifunctional compound IBU-PO protects from beta-amyloid neurotoxicity by acting on Wnt signaling components","volume":"18","author":"Far\u00edas","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2025.110754_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014382","article-title":"Lithium improves hippocampal neurogenesis, neuropathology and cognitive functions in APP mutant mice","volume":"5","author":"Fiorentini","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110754_bib63","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s12035-018-1103-z","article-title":"Impaired wnt signaling in the prefrontal cortex of Alzheimer's Disease","volume":"56","author":"Folke","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib64","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s007020070034","article-title":"Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3beta inhibition and in neurons","volume":"107","author":"Forlenza","year":"2000","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuropharm.2025.110754_bib65","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1021\/acschemneuro.0c00615","article-title":"Effect of QTC-4-MeOBnE treatment on memory, neurodegeneration, and neurogenesis in a streptozotocin-induced mouse model of Alzheimer's Disease","volume":"12","author":"Fronza","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib66","doi-asserted-by":"crossref","first-page":"6933","DOI":"10.1016\/j.bmcl.2013.09.020","article-title":"2-(2-Phenylmorpholin-4-yl)pyrimidin-4(3H)-ones; a new class of potent, selective and orally active glycogen synthase kinase-3\u03b2 inhibitors","volume":"23","author":"Fukunaga","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2025.110754_bib67","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.arr.2017.06.001","article-title":"The emerging role of Wnt signaling dysregulation in the understanding and modification of age-associated diseases","volume":"37","author":"Garc\u00eda-Vel\u00e1zquez","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuropharm.2025.110754_bib69","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.neuropharm.2025.110754_bib70","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3233\/JAD-201040","article-title":"Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment","volume":"80","author":"Guo","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuropharm.2025.110754_bib72","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The Amyloid-\u03b2 pathway in Alzheimer's Disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110754_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156523","article-title":"Lycium barbarum extract improves brain and visual functions in mice models of Alzheimer's disease through activating WNT pathway","volume":"139","author":"Han","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.neuropharm.2025.110754_bib75","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2025.110754_bib78","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1186\/s40880-015-0052-4","article-title":"Wnt3a: functions and implications in cancer","volume":"34","author":"He","year":"2015","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.neuropharm.2025.110754_bib79","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nm.4443","article-title":"Amyloid-\u03b2 plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation","volume":"24","author":"He","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2025.110754_bib80","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/bs.apha.2019.10.004","article-title":"Pharmacological effects of icariin","volume":"87","author":"He","year":"2020","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib81","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41576-024-00699-w","article-title":"The origin and evolution of Wnt signalling","volume":"25","author":"Holzem","year":"2024","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuropharm.2025.110754_bib82","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","article-title":"Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration","volume":"68","author":"Hoover","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110754_bib83","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejphar.2016.05.017","article-title":"Claulansine F promoted the neuronal differentiation of neural stem and progenitor cells through Akt\/GSK-3\u03b2\/\u03b2-catenin pathway","volume":"786","author":"Huang","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib84","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3389\/fnagi.2018.00164","article-title":"The role of fluoxetine in activating Wnt\/\u03b2-Catenin signaling and repressing \u03b2-Amyloid production in an alzheimer mouse model","volume":"10","author":"Huang","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib85","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8706400","article-title":"Hyperoside attenuate inflammation in HT22 cells via upregulating SIRT1 to activities Wnt\/\u03b2-Catenin and sonic Hedgehog pathways","volume":"2021","author":"Huang","year":"2021","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuropharm.2025.110754_bib86","article-title":"Miracle fruit seed as a potential supplement for the treatment of learning and memory disorders in Alzheimer's disease","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib87","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.1523\/JNEUROSCI.0889-12.2012","article-title":"Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease","volume":"32","author":"Hurtado","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib88","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/jmcb\/mjt051","article-title":"Wnt signaling in the nervous system and in Alzheimer's disease","volume":"6","author":"Inestrosa","year":"2014","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib89","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1034\/j.1600-0404.2000.00308.x","article-title":"Acetylcholinesterase-amyloid-beta-peptide interaction and Wnt signaling involvement in Abeta neurotoxicity","volume":"176","author":"Inestrosa","year":"2000","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.neuropharm.2025.110754_bib90","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3389\/fphar.2020.01225","article-title":"SIRT1 activation by natural phytochemicals: an overview","volume":"11","author":"Iside","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"196","key":"10.1016\/j.neuropharm.2025.110754_bib91","first-page":"e129","article-title":"Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal A\u03b2 aggregation in the 5XFAD mouse model of Alzheimer's disease","volume":"33","author":"Jawhar","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2025.110754_bib92","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13041-019-0525-5","article-title":"Restoring Wnt\/\u03b2-catenin signaling is a promising therapeutic strategy for Alzheimer's disease","volume":"12","author":"Jia","year":"2019","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuropharm.2025.110754_bib93","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3109\/00207454.2015.1008696","article-title":"Nicotine contributes to the neural stem cells fate against toxicity of microglial-derived factors induced by A\u03b2 via the Wnt\/\u03b2-catenin pathway","volume":"126","author":"Jiang","year":"2016","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107578","article-title":"Ginsenosides Rg1, Rb1 and rare ginsenosides: promising candidate agents for Parkinson's disease and Alzheimer's disease and network pharmacology analysis","volume":"212","author":"Jiang","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2025.110754_bib95","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.expneurol.2017.07.006","article-title":"Sodium selenate activated Wnt\/\u03b2-catenin signaling and repressed amyloid-\u03b2 formation in a triple transgenic mouse model of Alzheimer's disease","volume":"297","author":"Jin","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib96","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2122292119","article-title":"Modulation of amyloid precursor protein cleavage by \u03b3-secretase activating protein through phase separation","volume":"119","author":"Jin","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2025.110754_bib97","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4103\/1673-5374.320970","article-title":"Pathological mechanisms and therapeutic strategies for Alzheimer's disease","volume":"17","author":"Ju","year":"2022","journal-title":"Neural. Regen.Res"},{"key":"10.1016\/j.neuropharm.2025.110754_bib98","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13195-022-01034-3","article-title":"Phosphodiesterase 5 inhibitor mirodenafil ameliorates Alzheimer-like pathology and symptoms by multimodal actions","volume":"14","author":"Kang","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neuropharm.2025.110754_bib99","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.neuron.2015.05.046","article-title":"Building the neuronal microtubule Cytoskeleton","volume":"87","author":"Kapitein","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110754_bib100","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2174\/138945008784911750","article-title":"WNT signaling in stem cell biology and regenerative medicine","volume":"9","author":"Katoh","year":"2008","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.neuropharm.2025.110754_bib102","first-page":"95","volume":"7","author":"Kiriyama","year":"2018"},{"key":"10.1016\/j.neuropharm.2025.110754_bib103","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1016\/j.bmcl.2007.11.121","article-title":"Novel aryl and heteroaryl substituted N-[3-(4-phenylpiperazin-1-yl)propyl]-1,2,4-oxadiazole-5-carboxamides as selective GSK-3 inhibitors","volume":"18","author":"Koryakova","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2025.110754_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56075-w","article-title":"Modulation of Wnt\/\u03b2-catenin signaling promotes blood-brain barrier phenotype in cultured brain endothelial cells","volume":"9","author":"Laksitorini","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110754_bib105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer's disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neuropharm.2025.110754_bib106","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev-cellbio-100617-062608","article-title":"Development and cell biology of the blood-brain barrier","volume":"35","author":"Langen","year":"2019","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib107","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","article-title":"Neurodegenerative tauopathies","volume":"24","author":"Lee","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib108","article-title":"Ginkgolide B promotes neuronal differentiation through the Wnt\/\u03b2-catenin pathway in neural stem cells of the postnatal mammalian subventricular zone","volume":"8","author":"Li","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110754_bib109","doi-asserted-by":"crossref","first-page":"972","DOI":"10.4103\/1673-5374.324824","article-title":"Potential neuroprotection by Dendrobium nobile Lindl alkaloid in Alzheimer's disease models","volume":"17","author":"Li","year":"2022","journal-title":"Neural. Regen.Res"},{"key":"10.1016\/j.neuropharm.2025.110754_bib110","article-title":"Plasmalogen improves memory function by regulating neurogenesis in a mouse model of alzheimer's diseases","volume":"24","author":"Li","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116364","article-title":"Sanwei DouKou Decoction ameliorate Alzheimer disease by increasing endogenous neural stem cells proliferation through the Wnt\/\u03b2-catenin signalling pathway","volume":"309","author":"Li","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib112","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1021\/acschemneuro.8b00010","article-title":"Discovery of selective, Substrate-Competitive, and passive membrane permeable glycogen synthase Kinase-3\u03b2 inhibitors: synthesis, biological evaluation, and molecular modeling of new C-Glycosylflavones","volume":"9","author":"Liang","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib113","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jgr.2020.07.003","article-title":"20(S)-protopanaxadiol and oleanolic acid ameliorate cognitive deficits in APP\/PS1 transgenic mice by enhancing hippocampal neurogenesis","volume":"45","author":"Lin","year":"2021","journal-title":"J. Ginseng. Res."},{"key":"10.1016\/j.neuropharm.2025.110754_bib114","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuron.2014.08.048","article-title":"Deficiency in LRP6-mediated Wnt signaling contributes to synaptic abnormalities and amyloid pathology in Alzheimer's disease","volume":"84","author":"Liu","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110754_bib115","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1021\/acschemneuro.0c00520","article-title":"Development of Bisindole-Substituted aminopyrazoles as novel GSK-3\u03b2 inhibitors with suppressive effects against microglial inflammation and oxidative neurotoxicity","volume":"11","author":"Liu","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib116","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s11064-021-03227-y","article-title":"Interaction of NF-\u03baB and Wnt\/\u03b2-catenin signaling pathways in Alzheimer's Disease and potential active drug treatments","volume":"46","author":"Liu","year":"2021","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2025.110754_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117031","article-title":"Qingxin Kaiqiao Fang decreases Tau hyperphosphorylation in Alzheimer's disease via the PI3K\/Akt\/GSK3\u03b2 pathway in vitro and in vivo","volume":"318","author":"Liu","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25105123","article-title":"Curcumin improves neurogenesis in Alzheimer's Disease mice via the upregulation of Wnt\/\u03b2-Catenin and BDNF","volume":"25","author":"Lou","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib119","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1016\/j.bmcl.2014.05.085","article-title":"Syntheses, neural protective activities, and inhibition of glycogen synthase kinase-3\u03b2 of substituted quinolines","volume":"24","author":"Lu","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2025.110754_bib120","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1111\/1541-4337.12620","article-title":"Chlorogenic acid: a comprehensive review of the dietary sources, processing effects, bioavailability, beneficial properties, mechanisms of action, and future directions","volume":"19","author":"Lu","year":"2020","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"10.1016\/j.neuropharm.2025.110754_bib121","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/emboj\/20.1.27","article-title":"Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice","volume":"20","author":"Lucas","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2025.110754_bib122","article-title":"Amyloidosis in Alzheimer's Disease: Pathogeny, etiology, and related therapeutic directions","volume":"27","author":"Ma","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2025.110754_bib123","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/beta-catenin signaling: components, mechanisms, and diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev. Cell"},{"key":"10.1016\/j.neuropharm.2025.110754_bib124","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12035-022-03065-1","article-title":"Suppression of Wnt\/\u03b2-Catenin signaling is associated with downregulation of Wnt1, PORCN, and Rspo2 in Alzheimer's Disease","volume":"60","author":"Macyczko","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib125","doi-asserted-by":"crossref","first-page":"9359","DOI":"10.1074\/jbc.M707108200","article-title":"Amyloid-beta binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt\/beta-catenin signaling","volume":"283","author":"Magdesian","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2025.110754_bib126","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10522-021-09934-x","article-title":"Targeting Wnt signaling pathway by polyphenols: implication for aging and age-related diseases","volume":"22","author":"Maleki Dana","year":"2021","journal-title":"Biogerontology"},{"key":"10.1016\/j.neuropharm.2025.110754_bib127","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1007\/s11030-022-10395-8","article-title":"Molecular dynamics and structure-based virtual screening and identification of natural compounds as Wnt signaling modulators: possible therapeutics for Alzheimer's disease","volume":"26","author":"Manandhar","year":"2022","journal-title":"Mol. Divers."},{"key":"10.1016\/j.neuropharm.2025.110754_bib128","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.neuron.2022.03.004","article-title":"ApoE Cascade Hypothesis in the pathogenesis of Alzheimer's disease and related dementias","volume":"110","author":"Martens","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110754_bib129","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.89453.3","article-title":"Downregulation of Dickkopf-3, a Wnt antagonist elevated in Alzheimer's disease, restores synapse integrity and memory in a disease mouse model","volume":"12","author":"Martin Flores","year":"2024","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2025.110754_bib130","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.neubiorev.2021.06.029","article-title":"The transcriptional landscape of Alzheimer's disease and its association with Wnt signaling pathway","volume":"128","author":"Mart\u00ednez","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2025.110754_bib131","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.conb.2018.06.003","article-title":"Wnt proteins as modulators of synaptic plasticity","volume":"53","author":"McLeod","year":"2018","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib133","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in early Alzheimer's Disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2025.110754_bib134","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.bmcl.2008.01.113","article-title":"Rational design of 4-amino-5,6-diaryl-furo[2,3-d]pyrimidines as potent glycogen synthase kinase-3 inhibitors","volume":"18","author":"Miyazaki","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2025.110754_bib135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13024-023-00638-z","article-title":"Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer's disease","volume":"18","author":"Modeste","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2025.110754_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120613","article-title":"Infliximab and\/or MESNA alleviate doxorubicin-induced Alzheimer's disease-like pathology in rats: a new insight into TNF-\u03b1\/Wnt\/\u03b2-catenin signaling pathway","volume":"301","author":"Mohamad","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib137","doi-asserted-by":"crossref","first-page":"76135","DOI":"10.1007\/s11356-022-20611-5","article-title":"Boswellic acids ameliorate neurodegeneration induced by AlCl(3): the implication of Wnt\/\u03b2-catenin pathway","volume":"29","author":"Mohamed","year":"2022","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.neuropharm.2025.110754_bib138","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110754_bib139","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1021\/cn300110c","article-title":"Glycogen synthase kinase 3 inhibition promotes adult hippocampal neurogenesis in vitro and in vivo","volume":"3","author":"Morales-Garcia","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-016-0779-0","article-title":"Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease","volume":"14","author":"Moussa","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2025.110754_bib142","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s12031-021-01940-5","article-title":"Molecular insights to the wnt signaling during alzheimer's disorder: a potential target for therapeutic interventions","volume":"72","author":"Nagu","year":"2022","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102134","article-title":"GLP-1\/Sigma\/RAGE receptors: an evolving picture of Alzheimer's disease pathology and treatment","volume":"93","author":"Neha","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuropharm.2025.110754_bib144","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrm3470","article-title":"The complex world of WNT receptor signalling","volume":"13","author":"Niehrs","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib145","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5519330","article-title":"Lycopene-Loaded microemulsion regulates neurogenesis in rats with A\u03b2-Induced Alzheimer's Disease rats based on the Wnt\/\u03b2-catenin pathway","volume":"2021","author":"Ning","year":"2021","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuropharm.2025.110754_bib146","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14727","article-title":"Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease","volume":"8","author":"Nobili","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2025.110754_bib147","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1192\/bjp.bp.106.029868","article-title":"Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder","volume":"190","author":"Nunes","year":"2007","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110754_bib148","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/\u03b2-Catenin signaling, disease, and emerging therapeutic modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2025.110754_bib149","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pbiomolbio.2024.01.002","article-title":"Amyloid oligomers and their membrane toxicity - a perspective study","volume":"187","author":"Nutini","year":"2024","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib150","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1021\/acs.jcim.5b00486","article-title":"Structure-Based discovery of 1H-Indazole-3-carboxamides as a novel structural class of Human GSK-3 inhibitors","volume":"55","author":"Ombrato","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.neuropharm.2025.110754_bib151","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1474-4422(22)00168-5","article-title":"Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials","volume":"21","author":"Ossenkoppele","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib152","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11011-024-01489-3","article-title":"Aerobic exercise and metformin attenuate the cognitive impairment in an experimental model of type 2 diabetes mellitus: focus on neuroinflammation and adult hippocampal neurogenesis","volume":"40","author":"Padhy","year":"2025","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuropharm.2025.110754_bib153","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fncel.2019.00227","article-title":"Wnt signaling deregulation in the aging and alzheimer's brain","volume":"13","author":"Palomer","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib154","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nn.2583","article-title":"Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks","volume":"13","author":"Palop","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib155","doi-asserted-by":"crossref","first-page":"110380","DOI":"10.18632\/oncotarget.22777","article-title":"Neuroprotection by aripiprazole against \u03b2-amyloid-induced toxicity by P-CK2\u03b1 activation via inhibition of GSK-3\u03b2","volume":"8","author":"Park","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.neuropharm.2025.110754_bib156","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cub.2023.12.014","article-title":"Memory encoding and retrieval by retrosplenial parvalbumin interneurons are impaired in Alzheimer's disease model mice","volume":"34","author":"Park","year":"2024","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib157","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1128\/MCB.00930-12","article-title":"Glycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-\u03b2 precursor protein","volume":"32","author":"Parr","year":"2012","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib158","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1096\/fj.14-253211","article-title":"Activation of the Wnt\/\u03b2-catenin pathway represses the transcription of the \u03b2-amyloid precursor protein cleaving enzyme (BACE1) via binding of T-cell factor-4 to BACE1 promoter","volume":"29","author":"Parr","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2025.110754_bib159","doi-asserted-by":"crossref","DOI":"10.3390\/bioengineering10020192","article-title":"Identification of a novel Wnt antagonist based therapeutic and diagnostic target for Alzheimer's Disease using a stem cell-derived model","volume":"10","author":"Patil","year":"2023","journal-title":"Bioengineering"},{"key":"10.1016\/j.neuropharm.2025.110754_bib160","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/jat.4213","article-title":"The neuroprotective effects of alpha-lipoic acid on an experimental model of Alzheimer's disease in PC12 cells","volume":"42","author":"Pei","year":"2022","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib161","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28031168","article-title":"Neuroprotective effect of \u03b1-Lipoic acid against A\u03b2(25-35)-Induced damage in BV2 cells","volume":"28","author":"Pei","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2025.110754_bib162","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/ptr.5348","article-title":"A review: the pharmacology of isoliquiritigenin","volume":"29","author":"Peng","year":"2015","journal-title":"Phytother Res."},{"key":"10.1016\/j.neuropharm.2025.110754_bib163","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9440(10)63936-3","article-title":"Do neurons have a choice in death?","volume":"158","author":"Perry","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib164","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.16215","article-title":"Troriluzole rescues glutamatergic deficits, amyloid and tau pathology, and synaptic and memory impairments in 3xTg-AD mice","volume":"169","author":"Pfitzer","year":"2025","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110754_bib166","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1021\/acsmedchemlett.9b00633","article-title":"Optimization of indazole-based GSK-3 inhibitors with mitigated hERG issue and in vivo activity in a mood disorder model","volume":"11","author":"Prati","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2025.110754_bib167","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012078","article-title":"The flavonol quercitrin hinders GSK3 activity and potentiates the Wnt\/\u03b2-Catenin signaling pathway","volume":"23","author":"Predes","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib168","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1523\/JNEUROSCI.4562-11.2012","article-title":"The secreted Wnt antagonist Dickkopf-1 is required for amyloid \u03b2-mediated synaptic loss","volume":"32","author":"Purro","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib169","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.2147\/IJN.S374024","article-title":"Selenium nanoparticles-enriched Lactobacillus casei ATCC 393 prevents cognitive dysfunction in mice through modulating microbiota-gut-brain axis","volume":"17","author":"Qiao","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.neuropharm.2025.110754_bib170","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s12013-013-9516-9","article-title":"Effects of miR-19b overexpression on proliferation, differentiation, apoptosis and Wnt\/\u03b2-catenin signaling pathway in P19 cell model of cardiac differentiation in vitro","volume":"66","author":"Qin","year":"2013","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.neuropharm.2025.110754_bib171","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s13205-021-02900-x","article-title":"Shenzhiling oral solution promotes myelin repair through PI3K\/Akt-mTOR pathway in STZ-induced SAD mice","volume":"11","author":"Qin","year":"2021","journal-title":"3 Biotech"},{"key":"10.1016\/j.neuropharm.2025.110754_bib172","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.gendis.2023.01.030","article-title":"Canonical and noncanonical Wnt signaling: multilayered mediators, signaling mechanisms and major signaling crosstalk","volume":"11","author":"Qin","year":"2024","journal-title":"Genes. Dis."},{"key":"10.1016\/j.neuropharm.2025.110754_bib173","first-page":"2467","volume":"46","author":"Qirong","year":"2024"},{"key":"10.1016\/j.neuropharm.2025.110754_bib174","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fnmol.2020.00035","article-title":"Islet Amyloid Polypeptide: a Partner in Crime with A\u03b2 in the Pathology of Alzheimer's disease","volume":"13","author":"Raimundo","year":"2020","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.neuropharm.2025.110754_bib175","doi-asserted-by":"crossref","DOI":"10.3390\/cells11121885","article-title":"Innate immune cell death in neuroinflammation and Alzheimer's Disease","volume":"11","author":"Rajesh","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2025.110754_bib176","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1007\/s11064-020-03115-x","article-title":"Dimethyl fumarate mitigates tauopathy in A\u03b2-Induced neuroblastoma SH-SY5Y cells","volume":"45","author":"Rajput","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2025.110754_bib177","doi-asserted-by":"crossref","DOI":"10.3390\/diseases11030089","article-title":"WNT-\u03b2 catenin signaling as a potential therapeutic target for neurodegenerative diseases: current status and future perspective","volume":"11","author":"Ramakrishna","year":"2023","journal-title":"Diseases"},{"key":"10.1016\/j.neuropharm.2025.110754_bib178","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neulet.2008.01.034","article-title":"Lithium down-regulates tau in cultured cortical neurons: a possible mechanism of neuroprotection","volume":"434","author":"Rametti","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2025.110754_bib180","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41598-017-18729-5","article-title":"Amyloid \u03b2 causes excitation\/inhibition imbalance through dopamine receptor 1-dependent disruption of fast-spiking GABAergic input in anterior cingulate cortex","volume":"8","author":"Ren","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110754_bib181","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.phrs.2019.04.033","article-title":"The role of DKK1 in Alzheimer's disease: a potential intervention point of brain damage prevention?","volume":"144","author":"Ren","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2025.110754_bib182","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21134682","article-title":"Wnt\/\u03b2-Catenin signaling in oral carcinogenesis","volume":"21","author":"Reyes","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib184","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00702-015-1375-7","article-title":"Aberrant Wnt signaling pathway in medial temporal lobe structures of Alzheimer's disease","volume":"122","author":"Riise","year":"2015","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuropharm.2025.110754_bib186","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/1673-5374.262679","article-title":"Highlights of ASS234: a novel and promising therapeutic agent for Alzheimer's disease therapy","volume":"15","author":"Romero","year":"2020","journal-title":"Neural. Regen.Res"},{"key":"10.1016\/j.neuropharm.2025.110754_bib187","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010107","article-title":"Pathogenesis of Alzheimer's Disease","volume":"24","author":"Rostagno","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib188","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2014.11.014","article-title":"Neuroprotective potential of sesamol and its loaded solid lipid nanoparticles in ICV-STZ-induced cognitive deficits: behavioral and biochemical evidence","volume":"747","author":"Sachdeva","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib189","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1080\/1061186X.2024.2365263","article-title":"Unlocking hope: GSK-3 inhibitors and Wnt pathway activation in Alzheimer's therapy","volume":"32","author":"Sai Varshini","year":"2024","journal-title":"J. Drug Target."},{"key":"10.1016\/j.neuropharm.2025.110754_bib190","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/j.bmc.2009.01.019","article-title":"Design, synthesis and structure-activity relationships of 1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3beta","volume":"17","author":"Saitoh","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.neuropharm.2025.110754_bib191","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13195-021-00925-1","article-title":"In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer's disease phases","volume":"13","author":"Sala","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neuropharm.2025.110754_bib192","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11011-024-01515-4","article-title":"HMG-CoA reductase inhibitor simvastatin ameliorates trimethyltin neurotoxicity and cognitive impairment through reversal of Alzheimer's-associated markers","volume":"40","author":"Salari","year":"2024","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuropharm.2025.110754_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115697","article-title":"Tadalafil and bergapten mitigate streptozotocin-induced sporadic Alzheimer's disease in mice via modulating neuroinflammation, PI3K\/Akt, Wnt\/\u03b2-catenin, AMPK\/mTOR signaling pathways","volume":"429","author":"Salem","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib194","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.neulet.2006.07.045","article-title":"Lovastatin protects human neurons against Abeta-induced toxicity and causes activation of beta-catenin-TCF\/LEF signaling","volume":"412","author":"Salins","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2025.110754_bib195","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/jat.4513","article-title":"Antioxidant dihydrolipolic acid protects against in vitro aluminum-induced toxicity","volume":"43","author":"Sanajou","year":"2023","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib196","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1080\/01480545.2024.2303975","article-title":"Unraveling the neuroprotective mechanisms of naltrexone against aluminum-induced neurotoxicity","volume":"47","author":"Sanajou","year":"2024","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib197","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/jat.4695","article-title":"The ameliorative potential of metformin against aluminum-induced neurotoxicity: insights from in vitro studies","volume":"45","author":"Sanajou","year":"2025","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib198","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2406854121","article-title":"ERR\u03b1 and ERR\u03b3 coordinate expression of genes associated with Alzheimer's disease, inhibiting DKK1 to suppress tau phosphorylation","volume":"121","author":"Sato","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2025.110754_bib199","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.brainres.2012.12.015","article-title":"Estrogen regulation of Dkk1 and Wnt\/\u03b2-Catenin signaling in neurodegenerative disease","volume":"1514","author":"Scott","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110754_bib202","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1007\/s12035-023-03707-y","article-title":"Classic famous prescription kai-xin-san ameliorates Alzheimer's Disease via the Wnt\/\u03b2-Catenin signaling pathway","volume":"61","author":"Shan","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib203","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107378","article-title":"Impact of GSK-3\u03b2 and CK-1\u03b4 on Wnt signaling pathway in alzheimer disease: a dual target approach","volume":"147","author":"Sharma","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.neuropharm.2025.110754_bib204","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1021\/acs.jafc.2c08493","article-title":"Pteris laeta Wall. and its new phytochemical, pterosinsade A, promote hippocampal neurogenesis via activating the wnt signaling pathway","volume":"71","author":"Shi","year":"2023","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.neuropharm.2025.110754_bib205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25179418","article-title":"Anti-Warburg mechanism of ginsenoside F2 in human cervical cancer cells via activation of miR193a-5p and inhibition of \u03b2-Catenin\/c-Myc\/Hexokinase 2 signaling axis","volume":"25","author":"Shin","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib206","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neulet.2018.02.007","article-title":"Salvianolic acid B promotes neural differentiation of induced pluripotent stem cells via PI3K\/AKT\/GSK3\u03b2\/\u03b2-catenin pathway","volume":"671","author":"Shu","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2025.110754_bib207","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.2174\/1570159X15666170313123454","article-title":"Mechanisms of melatonin in alleviating Alzheimer's Disease","volume":"15","author":"Shukla","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib208","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12974-022-02565-0","article-title":"Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer's disease","volume":"19","author":"Singh","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2025.110754_bib209","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/med.21565","article-title":"Health benefits of resveratrol: evidence from clinical studies","volume":"39","author":"Singh","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.neuropharm.2025.110754_bib210","article-title":"The actions of lithium on glaucoma and other senile neurodegenerative diseases through GSK-3 inhibition: a narrative review","volume":"14","author":"Singh","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.neuropharm.2025.110754_bib211","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s12035-014-8899-y","article-title":"Neuroprotective role of novel triazine derivatives by activating Wnt\/\u03b2 Catenin signaling pathway in rodent models of Alzheimer's Disease","volume":"52","author":"Sinha","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib212","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2023.103322","article-title":"Molecular imaging of the association between serotonin degeneration and beta-amyloid deposition in mild cognitive impairment","volume":"37","author":"Smith","year":"2023","journal-title":"Neuroimage. Clin."},{"key":"10.1016\/j.neuropharm.2025.110754_bib214","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101503","article-title":"Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer's disease: a meta-analysis of in vivo magnetic resonance spectroscopy studies","volume":"72","author":"Song","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuropharm.2025.110754_bib215","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1172\/JCI81108","article-title":"Endothelial LRP1 transports amyloid-\u03b2(1-42) across the blood-brain barrier","volume":"126","author":"Storck","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuropharm.2025.110754_bib216","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153387","article-title":"Hyperoside ameliorates the progression of osteoarthritis: an in vitro and in vivo study","volume":"80","author":"Sun","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.neuropharm.2025.110754_bib217","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1007\/s12035-023-03672-6","article-title":"Cyanidin ameliorates bisphenol A-Induced Alzheimer's Disease pathology by restoring Wnt\/\u03b2-Catenin signaling Cascade: an In vitro Study","volume":"61","author":"Suresh","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib218","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.116953","article-title":"Cyanidin improves spatial memory and cognition in bisphenol A-induced rat model of alzheimer's-like neuropathology by restoring canonical Wnt signaling","volume":"487","author":"Suresh","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib219","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.3233\/JAD-220559","article-title":"Resveratrol mediated regulation of hippocampal neuroregenerative plasticity via SIRT1 pathway in synergy with wnt signaling: neurotherapeutic implications to mitigate memory loss in Alzheimer's Disease","volume":"94","author":"Surya","year":"2023","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.neuropharm.2025.110754_bib220","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202300245","article-title":"Amelioration of Amyloid-\u03b2 induced Alzheimer's Disease by Bacopa monnieri through modulation of mitochondrial dysfunction and GSK-3\u03b2\/Wnt\/\u03b2-Catenin signaling","volume":"68","author":"Sushma","year":"2024","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.neuropharm.2025.110754_bib221","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib222","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5604\/17322693.991446","article-title":"[The role of proteins in neurodegenerative disease]","volume":"66","author":"Szwed","year":"2012","journal-title":"Postepy Hig. Med. Dosw."},{"key":"10.1016\/j.neuropharm.2025.110754_bib224","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3920\/BM2019.0086","article-title":"Lactobacillus probiotics improved the gut microbiota profile of a Drosophila melanogaster Alzheimer's disease model and alleviated neurodegeneration in the eye","volume":"11","author":"Tan","year":"2020","journal-title":"Benef. Microbes"},{"key":"10.1016\/j.neuropharm.2025.110754_bib225","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bioorg.2018.01.040","article-title":"Synthesis of benzimidazole-linked-1,3,4-oxadiazole carboxamides as GSK-3\u03b2 inhibitors with in vivo antidepressant activity","volume":"77","author":"Tantray","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.neuropharm.2025.110754_bib226","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/jnc.14278","article-title":"Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice","volume":"144","author":"Tapia-Rojas","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110754_bib227","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1042\/BJ20140207","article-title":"Andrographolide activates the canonical Wnt signalling pathway by a mechanism that implicates the non-ATP competitive inhibition of GSK-3\u03b2: autoregulation of GSK-3\u03b2 in vivo","volume":"466","author":"Tapia-Rojas","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2025.110754_bib228","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/S0169-409X(02)00153-9","article-title":"Mood stabilizers in Alzheimer's disease: symptomatic and neuroprotective rationales","volume":"54","author":"Tariot","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.neuropharm.2025.110754_bib230","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bioorg.2018.06.018","article-title":"Design and synthesis of gallocyanine inhibitors of DKK1\/LRP6 interactions for treatment of Alzheimer's disease","volume":"80","author":"Thysiadis","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.neuropharm.2025.110754_bib231","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1021\/nn405077y","article-title":"Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer's disease model via canonical Wnt\/\u03b2-catenin pathway","volume":"8","author":"Tiwari","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.neuropharm.2025.110754_bib232","doi-asserted-by":"crossref","first-page":"28540","DOI":"10.1074\/jbc.M115.652586","article-title":"Ethosuximide induces hippocampal neurogenesis and reverses cognitive deficits in an Amyloid-\u03b2 toxin-induced alzheimer rat model via the phosphatidylinositol 3-Kinase (PI3K)\/Akt\/Wnt\/\u03b2-Catenin pathway","volume":"290","author":"Tiwari","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2025.110754_bib233","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.2147\/IJN.S200490","article-title":"Alzheimer's disease: pathogenesis, diagnostics, and therapeutics","volume":"14","author":"Tiwari","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.neuropharm.2025.110754_bib234","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/mp.2009.72","article-title":"Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe\/PSEN1DeltaE9 mouse model of Alzheimer's disease","volume":"15","author":"Toledo","year":"2010","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110754_bib235","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41419-022-04784-y","article-title":"Simvastatin rescues memory and granule cell maturation through the Wnt\/\u03b2-catenin signaling pathway in a mouse model of Alzheimer's disease","volume":"13","author":"Tong","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2025.110754_bib236","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2019.02.009","article-title":"Modulating Wnt signaling at the root: porcupine and Wnt acylation","volume":"198","author":"Torres","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2025.110754_bib237","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052810","article-title":"Neuroinflammation in schizophrenia: the key role of the WNT\/\u03b2-Catenin pathway","volume":"23","author":"Vall\u00e9e","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib238","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/abbs\/gmx073","article-title":"Effects of cannabidiol interactions with Wnt\/\u03b2-catenin pathway and PPAR\u03b3 on oxidative stress and neuroinflammation in Alzheimer's disease","volume":"49","author":"Vall\u00e9e","year":"2017","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.neuropharm.2025.110754_bib239","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.18632\/aging.102830","article-title":"Riluzole: a therapeutic strategy in Alzheimer's disease by targeting the WNT\/\u03b2-catenin pathway","volume":"12","author":"Vall\u00e9e","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.neuropharm.2025.110754_bib240","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11906-022-01209-1","article-title":"WNT\/\u03b2-catenin pathway: a possible link between hypertension and Alzheimer's Disease","volume":"24","author":"Vall\u00e9e","year":"2022","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.neuropharm.2025.110754_bib241","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's Disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2025.110754_bib242","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/935403","article-title":"Andrographolide stimulates neurogenesis in the adult Hippocampus","volume":"2015","author":"Varela-Nallar","year":"2015","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuropharm.2025.110754_bib243","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2024.105863","article-title":"Harmony of Wnt pathway in Alzheimer's: navigating the multidimensional progression from preclinical to clinical stages","volume":"165","author":"Varshini","year":"2024","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2025.110754_bib244","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/onc.2016.209","article-title":"Activation of CK1\u025b by PP2A\/PR61\u025b is required for the initiation of Wnt signaling","volume":"36","author":"Vinyoles","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.neuropharm.2025.110754_bib245","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/301575","article-title":"The role of Wnt signaling in the development of Alzheimer's disease: a potential therapeutic target?","volume":"2014","author":"Wan","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.neuropharm.2025.110754_bib246","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1745-7254.2006.00255.x","article-title":"Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine","volume":"27","author":"Wang","year":"2006","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2025.110754_bib247","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/npp.2010.245","article-title":"Huperzine A activates Wnt\/\u03b2-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model","volume":"36","author":"Wang","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110754_bib248","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.bbrc.2016.01.130","article-title":"Neuroprotective effects of Wnt\/\u03b2-catenin signaling pathway against A\u03b2 -induced tau protein over-phosphorylation in PC12 cells","volume":"471","author":"Wang","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2025.110754_bib249","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.7150\/thno.23877","article-title":"Cyclin D1-mediated microRNA expression signature predicts breast cancer outcome","volume":"8","author":"Wang","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.neuropharm.2025.110754_bib250","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136473","article-title":"Jujuboside a promotes proliferation and neuronal differentiation of APPswe-overexpressing neural stem cells by activating Wnt\/\u03b2-catenin signaling pathway","volume":"772","author":"Wang","year":"2022","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2025.110754_bib251","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1093\/brain\/awac236","article-title":"Activation of Wnt\/\u03b2-catenin pathway mitigates blood-brain barrier dysfunction in Alzheimer's disease","volume":"145","author":"Wang","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2025.110754_bib252","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154730","article-title":"A new gentiopicroside derivative improves cognitive deficits of AD mice via activation of Wnt signaling pathway and regulation of gut microbiota homeostasis","volume":"113","author":"Wang","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.neuropharm.2025.110754_bib253","article-title":"Protective effect of chlorogenic acid on cognitive impairment in rats with early Alzheimer's disease via Wnt signaling pathway","volume":"9","author":"Wang","year":"2025","journal-title":"J. Alzheimers. Dis. Rep."},{"key":"10.1016\/j.neuropharm.2025.110754_bib254","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.arr.2017.08.001","article-title":"Sirtuins, epigenetics and longevity","volume":"40","author":"W\u0105troba","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuropharm.2025.110754_bib255","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2022.105385","article-title":"Resveratrol ameliorates learning and memory impairments induced by bilateral hippocampal injection of streptozotocin in mice","volume":"159","author":"Wei","year":"2022","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2025.110754_bib256","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0165-6147(99)01428-5","article-title":"Lithium therapy and signal transduction","volume":"21","author":"Williams","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib257","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/CIRCULATIONAHA.116.024441","article-title":"Opposing roles of wnt inhibitors IGFBP-4 and Dkk1 in cardiac ischemia by differential targeting of LRP5\/6 and \u03b2-catenin","volume":"134","author":"Wo","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.neuropharm.2025.110754_bib258","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1002\/ptr.7022","article-title":"Icarisid II promotes proliferation and neuronal differentiation of neural stem cells via activating Wnt\/\u03b2-catenin signaling pathway","volume":"35","author":"Xiao","year":"2021","journal-title":"Phytother Res."},{"key":"10.1016\/j.neuropharm.2025.110754_bib259","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1002\/ptr.7430","article-title":"Icarisid II rescues cognitive dysfunction via activation of Wnt\/\u03b2-catenin signaling pathway promoting hippocampal neurogenesis in APP\/PS1 transgenic mice","volume":"36","author":"Xiao","year":"2022","journal-title":"Phytother Res."},{"key":"10.1016\/j.neuropharm.2025.110754_bib260","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/cns.14139","article-title":"Upregulation of Wnt2b exerts neuroprotective effect by alleviating mitochondrial dysfunction in Alzheimer's disease","volume":"29","author":"Xu","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2025.110754_bib261","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1089\/rej.2022.0063","article-title":"Kai-Xin-San improves cognitive impairment via Wnt\/\u03b2-Catenin and IRE1\/XBP1s signalings in APP\/PS1 mice","volume":"26","author":"Xu","year":"2023","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.neuropharm.2025.110754_bib262","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1056614","article-title":"Effects of Broussonetia papyrifera (L.) L'H\u00e9r. ex Vent. fruits water extract on hippocampal neurogenesis in the treatment of APP\/PS1 transgenic mice","volume":"13","author":"Yan","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib263","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106663","article-title":"Synthesis and biological evaluation of thieno[3,2-c]pyrazol-3-amine derivatives as potent glycogen synthase kinase 3\u03b2 inhibitors for Alzheimer's disease","volume":"138","author":"Yan","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.neuropharm.2025.110754_bib264","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1159\/000485580","article-title":"The key roles of GSK-3\u03b2 in regulating mitochondrial activity","volume":"44","author":"Yang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.neuropharm.2025.110754_bib265","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/cbdd.14041","article-title":"Ginsenoside Rg1 improves Alzheimer's disease by regulating oxidative stress, apoptosis, and neuroinflammation through Wnt\/GSK-3\u03b2\/\u03b2-catenin signaling pathway","volume":"99","author":"Yang","year":"2022","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.neuropharm.2025.110754_bib266","article-title":"Presenilin-1 (PSEN1) mutations: clinical phenotypes beyond Alzheimer's Disease","volume":"24","author":"Yang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib267","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.taap.2015.10.013","article-title":"Osthole promotes neuronal differentiation and inhibits apoptosis via Wnt\/\u03b2-catenin signaling in an Alzheimer's disease model","volume":"289","author":"Yao","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib268","doi-asserted-by":"crossref","first-page":"9081","DOI":"10.3892\/mmr.2017.7702","article-title":"Puerarin inhibits \u03b2-amyloid peptide 1-42-induced tau hyperphosphorylation via the Wnt\/\u03b2-catenin signaling pathway","volume":"16","author":"Yao","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.neuropharm.2025.110754_bib269","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1016\/j.bmc.2009.05.031","article-title":"Synthesis and biological evaluation of novel 4-azaindolyl-indolyl-maleimides as glycogen synthase kinase-3beta (GSK-3beta) inhibitors","volume":"17","author":"Ye","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.neuropharm.2025.110754_bib270","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.bmc.2014.12.026","article-title":"Synthesis and biological evaluation of 3-([1,2,4]triazolo[4,3-a]pyridin-3-yl)-4-(indol-3-yl)-maleimides as potent, selective GSK-3\u03b2 inhibitors and neuroprotective agents","volume":"23","author":"Ye","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.neuropharm.2025.110754_bib271","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.131841","article-title":"Design and in vitro evaluation of curcumin-loaded PLGA nanoparticle-embedded sodium alginate\/gelatin 3D printed scaffolds for Alzheimer's disease","volume":"268","author":"Yekeler","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib272","doi-asserted-by":"crossref","DOI":"10.3390\/md19030152","article-title":"Dieckol ameliorates A\u03b2 production via PI3K\/Akt\/GSK-3\u03b2 regulated APP processing in SweAPP N2a cell","volume":"19","author":"Yoon","year":"2021","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.neuropharm.2025.110754_bib273","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106836","article-title":"Inhibition of CXXC5 function rescues Alzheimer's disease phenotypes by restoring Wnt\/\u03b2-catenin signaling pathway","volume":"194","author":"Yoon","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2025.110754_bib274","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41392-021-00701-5","article-title":"Wnt\/\u03b2-catenin signaling in cancers and targeted therapies","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.neuropharm.2025.110754_bib275","doi-asserted-by":"crossref","first-page":"6190","DOI":"10.1021\/acs.jafc.9b01436","article-title":"ApoE-Dependent protective effects of sesamol on high-fat diet-induced behavioral disorders: regulation of the microbiome-gut-brain axis","volume":"67","author":"Yuan","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.neuropharm.2025.110754_bib276","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bioorg.2015.05.009","article-title":"Structure-based design of benzo[e]isoindole-1,3-dione derivatives as selective GSK-3\u03b2 inhibitors to activate Wnt\/\u03b2-catenin pathway","volume":"61","author":"Yue","year":"2015","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.neuropharm.2025.110754_bib277","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.mito.2022.03.003","article-title":"The war against Alzheimer, the mitochondrion strikes back","volume":"64","author":"Zambrano","year":"2022","journal-title":"Mitochondrion"},{"key":"10.1016\/j.neuropharm.2025.110754_bib278","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fnagi.2019.00062","article-title":"Valproic acid stimulates hippocampal neurogenesis via activating the Wnt\/\u03b2-Catenin signaling pathway in the APP\/PS1\/Nestin-GFP triple transgenic mouse model of Alzheimer's Disease","volume":"11","author":"Zeng","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib279","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/j.bmcl.2004.03.090","article-title":"3-(7-Azaindolyl)-4-arylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3","volume":"14","author":"Zhang","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2025.110754_bib280","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1111\/j.1460-9568.2009.07017.x","article-title":"Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic\/axonal pathology and amyloidogenesis: implications for neuritic plaque development","volume":"30","author":"Zhang","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib281","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/cns.12594","article-title":"L-3-n-butylphthalide Rescues Hippocampal synaptic failure and attenuates neuropathology in aged APP\/PS1 mouse model of Alzheimer's Disease","volume":"22","author":"Zhang","year":"2016","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2025.110754_bib282","doi-asserted-by":"crossref","first-page":"26448","DOI":"10.1073\/pnas.2005395117","article-title":"Neddylation is critical to cortical development by regulating Wnt\/\u03b2-catenin signaling","volume":"117","author":"Zhang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2025.110754_bib283","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13020-021-00486-3","article-title":"The emerging possibility of the use of geniposide in the treatment of cerebral diseases: a review","volume":"16","author":"Zhang","year":"2021","journal-title":"Chin. Med."},{"key":"10.1016\/j.neuropharm.2025.110754_bib284","doi-asserted-by":"crossref","first-page":"313","DOI":"10.14283\/jpad.2021.15","article-title":"The epidemiology of Alzheimer's Disease modifiable risk factors and prevention","volume":"8","author":"Zhang","year":"2021","journal-title":"J. Prev. Alzheimers. Dis"},{"key":"10.1016\/j.neuropharm.2025.110754_bib285","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10071500","article-title":"Deletion of Wnt10a is implicated in hippocampal neurodegeneration in mice","volume":"10","author":"Zhang","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuropharm.2025.110754_bib286","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3233\/JAD-215433","article-title":"Dendrobium nobile lindl. Alkaloids ameliorate A\u03b225-35-Induced synaptic deficits by targeting Wnt\/\u03b2-Catenin pathway in Alzheimer's Disease models","volume":"86","author":"Zhang","year":"2022","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.neuropharm.2025.110754_bib287","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.70056","article-title":"Danggui Shaoyao San Alleviates early cognitive impairment in Alzheimer's Disease mice through IRS1\/GSK3\u03b2\/Wnt3a-\u03b2-Catenin pathway","volume":"14","author":"Zhang","year":"2024","journal-title":"Brain. Behav."},{"key":"10.1016\/j.neuropharm.2025.110754_bib288","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140692","article-title":"Harnessing the power of ginger leaf polysaccharide: a potential strategy to combat A\u03b2-induced toxicity through the Wnt\/\u03b2-catenin pathway","volume":"303","author":"Zhang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.neuropharm.2025.110754_bib289","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12630","article-title":"Structural characterization of melatonin as an inhibitor of the Wnt deacylase Notum","volume":"68","author":"Zhao","year":"2020","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.neuropharm.2025.110754_bib290","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bbrc.2017.01.069","article-title":"Selenomethionine promoted hippocampal neurogenesis via the PI3K-Akt-GSK3\u03b2-Wnt pathway in a mouse model of Alzheimer's disease","volume":"485","author":"Zheng","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2025.110754_bib291","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154890","article-title":"Molecular mechanisms and therapeutic potential of icariin in the treatment of Alzheimer's disease","volume":"116","author":"Zheng","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.neuropharm.2025.110754_bib292","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1039\/B905752H","article-title":"Characterization and development of novel small-molecules inhibiting GSK3 and activating Wnt signaling","volume":"5","author":"Zhong","year":"2009","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.neuropharm.2025.110754_bib293","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/iub.2862","article-title":"Neuroprotection and mechanisms of ginsenosides in nervous system diseases: progress and perspectives","volume":"76","author":"Zhou","year":"2024","journal-title":"IUBMB Life"},{"key":"10.1016\/j.neuropharm.2025.110754_bib294","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.trci.2018.09.009","article-title":"A randomized, double-blind, placebo-controlled trial of resveratrol with glucose and malate (RGM) to slow the progression of Alzheimer's disease: a pilot study","volume":"4","author":"Zhu","year":"2018","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuropharm.2025.110754_bib295","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s12576-017-0561-9","article-title":"Xanthoceraside modulates neurogenesis to ameliorate cognitive impairment in APP\/PS1 transgenic mice","volume":"68","author":"Zhu","year":"2018","journal-title":"J. Physiol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib296","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12868-019-0520-x","article-title":"Isoliquiritigenin attenuates lipopolysaccharide-induced cognitive impairment through antioxidant and anti-inflammatory activity","volume":"20","author":"Zhu","year":"2019","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110754_bib297","first-page":"1","article-title":"Associations between gut microbiota and Alzheimer's disease","volume":"17","author":"Zhuang","year":"2020","journal-title":"major. depressive. disorder. schizophrenia"},{"key":"10.1016\/j.neuropharm.2025.110754_bib298","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3233\/JAD-170701","article-title":"Neuroprotective effects of ferruginol, Jatrophone, and junicedric acid against Amyloid-\u03b2 injury in hippocampal neurons","volume":"63","author":"Zolezzi","year":"2018","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.neuropharm.2025.110754_bib299","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/10738584241246530","article-title":"TRP channels in excitotoxicity","volume":"31","author":"Zong","year":"2025","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2025.110754_bib300","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1021\/jm9013373","article-title":"Benzo[e]isoindole-1,3-diones as potential inhibitors of glycogen synthase kinase-3 (GSK-3). Synthesis, kinase inhibitory activity, zebrafish phenotype, and modeling of binding mode","volume":"53","author":"Zou","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2025.110754_bib301","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/10715762.2012.742518","article-title":"Protective effect of puerarin against beta-amyloid-induced oxidative stress in neuronal cultures from rat hippocampus: involvement of the GSK-3\u03b2\/Nrf2 signaling pathway","volume":"47","author":"Zou","year":"2013","journal-title":"Free Radic. Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825004629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825004629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T08:20:44Z","timestamp":1780820444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825004629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":281,"alternative-id":["S0028390825004629"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110754","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association of the Wnt\/\u03b2-catenin signaling pathway with Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110754","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110754"}}